223 related articles for article (PubMed ID: 2553814)
1. Synergistic effects of phorbol ester and INF-gamma on the induction of indoleamine 2,3-dioxygenase in THP-1 monocytic leukemia cells.
Edelstein MP; Ozaki Y; Duch DS
J Immunol; 1989 Nov; 143(9):2969-73. PubMed ID: 2553814
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
[TBL] [Abstract][Full Text] [Related]
3. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.
Däubener W; Remscheid C; Nockemann S; Pilz K; Seghrouchni S; Mackenzie C; Hadding U
Eur J Immunol; 1996 Feb; 26(2):487-92. PubMed ID: 8617321
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells.
Malone DG; Dolan PW; Brown RR; Kalayoglu MV; Arend RA; Byrne GI; Ozaki Y
J Rheumatol; 1994 Jun; 21(6):1011-9. PubMed ID: 7523670
[TBL] [Abstract][Full Text] [Related]
5. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines.
Fujigaki H; Saito K; Fujigaki S; Takemura M; Sudo K; Ishiguro H; Seishima M
J Biochem; 2006 Apr; 139(4):655-62. PubMed ID: 16672265
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection.
Takikawa O; Habara-Ohkubo A; Yoshida R
J Immunol; 1990 Aug; 145(4):1246-50. PubMed ID: 2116480
[TBL] [Abstract][Full Text] [Related]
8. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease.
Yamada A; Akimoto H; Kagawa S; Guillemin GJ; Takikawa O
J Neurochem; 2009 Aug; 110(3):791-800. PubMed ID: 19457071
[TBL] [Abstract][Full Text] [Related]
10. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling.
Kawaguchi R; Shimokawa T; Umehara N; Nunomura S; Tanaka T; Ra C
J Reprod Immunol; 2008 Apr; 77(2):117-25. PubMed ID: 17942160
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.
Alberati-Giani D; Malherbe P; Ricciardi-Castagnoli P; Köhler C; Denis-Donini S; Cesura AM
J Immunol; 1997 Jul; 159(1):419-26. PubMed ID: 9200481
[TBL] [Abstract][Full Text] [Related]
12. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
López AS; Alegre E; Díaz A; Mugueta C; González A
Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
[TBL] [Abstract][Full Text] [Related]
13. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
[TBL] [Abstract][Full Text] [Related]
14. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
Fallarini S; Paoletti T; Panza L; Lombardi G
Biochem Pharmacol; 2008 Sep; 76(6):738-50. PubMed ID: 18671950
[TBL] [Abstract][Full Text] [Related]
15. Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C.
Li Q; Bever CT
Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):375-96. PubMed ID: 8872491
[TBL] [Abstract][Full Text] [Related]
16. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma.
Recht M; Borden EC; Knight E
J Immunol; 1991 Oct; 147(8):2617-23. PubMed ID: 1717569
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Fc gamma receptor expression and phagocytosis of a human monoblast cell line U937. Participation of cAMP and protein kinase C in the effects of IFN-gamma and phorbol ester.
Nambu M; Morita M; Watanabe H; Uenoyama Y; Kim KM; Tanaka M; Iwai Y; Kimata H; Mayumi M; Mikawa H
J Immunol; 1989 Dec; 143(12):4158-65. PubMed ID: 2556478
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.
Babcock TA; Carlin JM
Cytokine; 2000 Jun; 12(6):588-94. PubMed ID: 10843733
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes.
Hu B; Hissong BD; Carlin JM
J Interferon Cytokine Res; 1995 Jul; 15(7):617-24. PubMed ID: 7553232
[TBL] [Abstract][Full Text] [Related]
20. Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells.
Li Q; Milo R; Panitch H; Bever CT
Immunopharmacol Immunotoxicol; 1998 Feb; 20(1):39-61. PubMed ID: 9543699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
